The Aicardi Syndrome Treatment Market is primarily focused on symptomatic management and supportive care. Since the specific gene responsible for the syndrome remains unidentified, treatments target the debilitating neurological and physiological symptoms. In 2026, the market is benefiting from increased genomic research and the "orphan drug" movement, which provides incentives for ph... https://logcla.com/blogs/947640/Low-Zero-Sugar-Energy-Drinks-Segment-Dominance-and-Revenue-Projection